000 01611 a2200469 4500
005 20250512233920.0
264 0 _c19830311
008 198303s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/1097-0142(19830201)51:3<396::aid-cncr2820510307>3.0.co;2-a
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAntman, K H
245 0 0 _aSurvival of patients with localized high-grade soft tissue sarcoma with multimodality therapy. A matched control study.
_h[electronic resource]
260 _bCancer
_cFeb 1983
300 _a396-401 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aChild
650 0 4 _aCyclophosphamide
_xadministration & dosage
650 0 4 _aDacarbazine
_xadministration & dosage
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Staging
650 0 4 _aProbability
650 0 4 _aPrognosis
650 0 4 _aSarcoma
_xmortality
650 0 4 _aSoft Tissue Neoplasms
_xmortality
700 1 _aBlum, R H
700 1 _aWilson, R E
700 1 _aCorson, J M
700 1 _aGreenberger, J S
700 1 _aAmato, D A
700 1 _aCanellos, G P
700 1 _aFrei, E
773 0 _tCancer
_gvol. 51
_gno. 3
_gp. 396-401
856 4 0 _uhttps://doi.org/10.1002/1097-0142(19830201)51:3<396::aid-cncr2820510307>3.0.co;2-a
_zAvailable from publisher's website
999 _c6821561
_d6821561